These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

92 related items for PubMed ID: 2852985

  • 21. [Structural changes in the central nervous system of rats in manganese chloride (MnCl2) poisoning].
    Gajkowska B, Kosicka B, Smiałek M.
    Neuropatol Pol; 1987; 25(4):523-37. PubMed ID: 3454883
    [No Abstract] [Full Text] [Related]

  • 22. α-Synuclein protects against manganese neurotoxic insult during the early stages of exposure in a dopaminergic cell model of Parkinson's disease.
    Harischandra DS, Jin H, Anantharam V, Kanthasamy A, Kanthasamy AG.
    Toxicol Sci; 2015 Feb; 143(2):454-68. PubMed ID: 25416158
    [Abstract] [Full Text] [Related]

  • 23. Protective effects of Vitamin E on endocrine disruptors, PCB-induced dopaminergic neurotoxicity.
    Yun JS, Na HK, Park KS, Lee YH, Kim EY, Lee SY, Kim JI, Kang JH, Kim DS, Choi KH.
    Toxicology; 2005 Dec 15; 216(2-3):140-6. PubMed ID: 16182432
    [Abstract] [Full Text] [Related]

  • 24. EGb761 protects against nigrostriatal dopaminergic neurotoxicity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice: role of oxidative stress.
    Rojas P, Serrano-García N, Mares-Sámano JJ, Medina-Campos ON, Pedraza-Chaverri J, Ogren SO.
    Eur J Neurosci; 2008 Jul 15; 28(1):41-50. PubMed ID: 18662333
    [Abstract] [Full Text] [Related]

  • 25. Chronic organic manganese administration in the rat does not damage dopaminergic nigrostriatal neurons.
    Yong VW, Perry TL, Godolphin WJ, Jones KA, Clavier RM, Ito M, Foulks JG.
    Neurotoxicology; 1986 Jul 15; 7(1):19-24. PubMed ID: 2872639
    [Abstract] [Full Text] [Related]

  • 26. Postnatal manganese exposure attenuates cocaine-induced locomotor activity and reduces dopamine transporters in adult male rats.
    Reichel CM, Wacan JJ, Farley CM, Stanley BJ, Crawford CA, McDougall SA.
    Neurotoxicol Teratol; 2006 Jul 15; 28(3):323-32. PubMed ID: 16571372
    [Abstract] [Full Text] [Related]

  • 27. Altered striatal dopamine release following a sub-acute exposure to manganese.
    Khalid M, Aoun RA, Mathews TA.
    J Neurosci Methods; 2011 Nov 15; 202(2):182-91. PubMed ID: 21740928
    [Abstract] [Full Text] [Related]

  • 28. Effects of MK-801, taurine and dextromethorphan on neurotoxicity caused by manganese in rats.
    Xu Z, Jia K, Xu B, He A, Li J, Deng Y, Zhang F.
    Toxicol Ind Health; 2010 Feb 15; 26(1):55-60. PubMed ID: 20056741
    [Abstract] [Full Text] [Related]

  • 29. Alteration in some membrane properties in rat brain following exposure to manganese.
    Kumar R, Srivastava S, Agrawal AK, Seth PK.
    Pharmacol Toxicol; 1996 Jul 15; 79(1):47-8. PubMed ID: 8841096
    [No Abstract] [Full Text] [Related]

  • 30. Effects of a fluorinated pyrimidinedione anti-cancer drug, 5-fluoro-1-(tetrahydro-2-furanyl)-2,4-pyrimidinedione (FT), and related compounds on nigro-striatal dopaminergic neurons in the central nervous system.
    Toide K, Unemi N, Segawa T.
    Arch Int Pharmacodyn Ther; 1985 Mar 15; 274(1):111-24. PubMed ID: 3925907
    [Abstract] [Full Text] [Related]

  • 31. Selective vulnerability of glutathione metabolism and cellular defense mechanisms in rat striatum to manganese.
    Liccione JJ, Maines MD.
    J Pharmacol Exp Ther; 1988 Oct 15; 247(1):156-61. PubMed ID: 2902211
    [Abstract] [Full Text] [Related]

  • 32. S-allyl cysteine protects against MPTP-induced striatal and nigral oxidative neurotoxicity in mice: participation of Nrf2.
    García E, Santana-Martínez R, Silva-Islas CA, Colín-González AL, Galván-Arzate S, Heras Y, Maldonado PD, Sotelo J, Santamaría A.
    Free Radic Res; 2014 Feb 15; 48(2):159-67. PubMed ID: 24147739
    [Abstract] [Full Text] [Related]

  • 33. NMDA receptors modulate dopamine loss due to energy impairment in the substantia nigra but not striatum.
    Zeevalk GD, Manzino L, Sonsalla PK.
    Exp Neurol; 2000 Feb 15; 161(2):638-46. PubMed ID: 10686083
    [Abstract] [Full Text] [Related]

  • 34. Effects of amfonelic acid, alpha-methyltyrosine, Ro 4-1284 and haloperidol pretreatment on the depletion of striatal dopamine by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice.
    Fuller RW, Hemrick-Luecke SK.
    Res Commun Chem Pathol Pharmacol; 1985 Apr 15; 48(1):17-25. PubMed ID: 3873102
    [Abstract] [Full Text] [Related]

  • 35. In vivo studies on the enhancement of cholecystokinin release in the rat striatum by dopamine depletion.
    Butcher SP, Varro A, Kelly JS, Dockray GJ.
    Brain Res; 1989 Dec 25; 505(1):119-22. PubMed ID: 2611663
    [Abstract] [Full Text] [Related]

  • 36. Intranigral substance P stimulation of striatal dopamine release is inhibited by spantide II: a new tachykinin antagonist without apparent neurotoxicity.
    Reid MS, Hökfelt T, Herrera-Marschitz M, Håkanson R, Feng DM, Folkers K, Goldstein M, Ungerstedt U.
    Brain Res; 1990 Nov 05; 532(1-2):175-81. PubMed ID: 1704289
    [Abstract] [Full Text] [Related]

  • 37. Endogenous dopamine enhances the neurotoxicity of 3-nitropropionic acid in the striatum through the increase of mitochondrial respiratory inhibition and free radicals production.
    Villarán RF, Tomás-Camardiel M, de Pablos RM, Santiago M, Herrera AJ, Navarro A, Machado A, Cano J.
    Neurotoxicology; 2008 Mar 05; 29(2):244-58. PubMed ID: 18093658
    [Abstract] [Full Text] [Related]

  • 38. Effects of 1,3-bis(tetrahydro-2-furanyl)-5-fluoro-2,4-pyrimidinedione (FD 1) on the central nervous system: (2) Effects on nigro-striatal dopaminergic neurons.
    Toide K, Kitazato K, Unemi N.
    Arch Int Pharmacodyn Ther; 1981 Jul 05; 252(1):106-12. PubMed ID: 6118104
    [Abstract] [Full Text] [Related]

  • 39. Manganese does not alter the severe neurotoxicity of MPTP.
    Baek SY, Kim YH, Oh SO, Lee CR, Yoo CI, Lee JH, Lee H, Sim CS, Park J, Kim JW, Yoon CS, Kim Y.
    Hum Exp Toxicol; 2007 Mar 05; 26(3):203-11. PubMed ID: 17439923
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.